Announcements Trials
Browse Landscape

Phase

Phase NA 104Phase 2 16Phase 3 11Phase 1 6Phase EARLY_PHASE1 2Phase 2/3 2Phase 1/2 2

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1CNS 1

Conditions

Smoking 1Oligodendroglioma 1Lung Neoplasms 1Glioma 1Astrocytoma 1

Interventions

Magnetic Resonance Spectroscopy 26pembrolizumab 17Specimen Handling 17Radiotherapy 17Nivolumab 15Cyclophosphamide 14Temozolomide 11Biopsy 11Fluorodeoxyglucose F18 10fludarabine 9X-Rays 9Etoposide 7Bevacizumab 7Standard of Care 6Radiation 6Paclitaxel 6Dexamethasone 6Cisplatin 6Carboplatin 6Surgical Procedures, Operative 5Ipilimumab 5Doxorubicin 5Aspirin 5venetoclax 4olaparib 4fluciclovine F-18 4atezolizumab 4abemaciclib 4Vincristine 4Rituximab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Practice Guidelines as Topic × 1 year × Clear all
NCT03796273 2026-03-20

Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases

Wake Forest University Health Sciences

Phase EARLY_PHASE1 Terminated
15 enrolled
CNS

Astrocytoma, Glioma, Oligodendroglioma

NCT04200534 2025-08-22

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
358 enrolled
Thoracic

Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡